Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This target complex comprises three distinct ion channels—Transient receptor potential vanilloid 1 (TRPV1), Piezo-type mechanosensitive ion channel component 2 (Piezo2), and P2X purinoceptor 3 (P2X3)—integrated within local neuroimmune pathways. TRPV1 serves as a polymodal sensor for noxious heat, protons, and vanilloids, playing a central role in thermal hyperalgesia (Caterina et al., 1997; UniProt P35497). Piezo2 is the primary transducer of mechanical stimuli, essential for light touch and proprioception, and is implicated in mechanical allodynia (Coste et al., 2010; UniProt Q9H5I5). P2X3 is an ATP-gated channel expressed on sensory neurons that mediates pain and the urge to cough following tissue injury (Burnstock, 2018; UniProt P56373). The interaction of these channels with local neuroimmune pathways involves the release of neuropeptides and cytokines that sensitize peripheral nociceptors, creating a state of chronic hypersensitivity (Pinho-Ribeiro et al., 2017). Pharmacological targeting of this axis, such as through P2X3 antagonists like Gefapixant or TRPV1 agonists like Capsaicin, aims to modulate sensory input to treat conditions like chronic refractory cough and neuropathic pain.
Antagonism or desensitization of sensory ion channels to inhibit the transmission of noxious stimuli and disrupt the inflammatory feedback loop between neurons and immune cells.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transient receptor potential vanilloid 1, Piezo-type mechanosensitive ion channel component 2, and P2X purinoceptor 3 neuroimmune axis (TRPV1/Piezo2/P2X3).